G

Gelesis

83 employees

Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Obesity
Medical Device
Diabetes
Medical Devices
Health Care

Date founded

2006

Funding rounds raised

Total raised

$100M

from 8 investors over 8 rounds

G

Gelesis raised $100M on January 14, 2022

Investors: Pritzker Vlock Family Office and Kennedy Lewis Investment Management LLC

G

Gelesis raised undisclosed on January 18, 2021

Investors: Hambro Perks

G

Gelesis raised $84M on December 9, 2019

Investors: Vitruvian Partners

G

Gelesis raised $32M on December 18, 2015

Investors: Pritzker Vlock Family Office and PureTech Health

G

Gelesis raised $12M on May 16, 2014

Investors: Pritzker Vlock Family Office and PureTech Health

FAQ